J. Mark Treherne

1.8k total citations
43 papers, 1.3k citations indexed

About

J. Mark Treherne is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, J. Mark Treherne has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Physiology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in J. Mark Treherne's work include Alzheimer's disease research and treatments (9 papers), Computational Drug Discovery Methods (9 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). J. Mark Treherne is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Computational Drug Discovery Methods (9 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). J. Mark Treherne collaborates with scholars based in United Kingdom, Switzerland and United States. J. Mark Treherne's co-authors include Michael L.J. Ashford, P. Boden, J. G. Nicholls, L. Mike Furness, Ross A. Kinloch, Norman R. Saunders, J.M. Young, Mark Bushfield, D. I. C. SCOPES and Kjeld Møllgård and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Physiology and Nature Reviews Drug Discovery.

In The Last Decade

J. Mark Treherne

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Mark Treherne United Kingdom 18 607 546 231 212 185 43 1.3k
Atsuko Kimura Japan 31 1.4k 2.3× 479 0.9× 95 0.4× 280 1.3× 105 0.6× 82 2.3k
Juan José Garrido Spain 26 1.1k 1.8× 960 1.8× 111 0.5× 299 1.4× 221 1.2× 50 2.2k
Donna Bozyczko‐Coyne United States 25 917 1.5× 481 0.9× 113 0.5× 230 1.1× 59 0.3× 30 1.7k
Carsten Strübing Germany 19 1.7k 2.8× 1.2k 2.1× 160 0.7× 293 1.4× 125 0.7× 24 3.1k
Ludmila Mackerlova Sweden 14 579 1.0× 493 0.9× 130 0.6× 168 0.8× 154 0.8× 19 1.4k
Ross D. O’Shea Australia 22 703 1.2× 783 1.4× 167 0.7× 237 1.1× 176 1.0× 40 1.7k
E. Barry Smalstig United States 17 808 1.3× 644 1.2× 68 0.3× 201 0.9× 85 0.5× 38 2.0k
Hiroko Sugiura Japan 22 1.1k 1.8× 713 1.3× 80 0.3× 210 1.0× 98 0.5× 38 2.0k
Sigismund Huck Austria 28 1.2k 1.9× 958 1.8× 127 0.5× 149 0.7× 49 0.3× 69 1.9k
Glauco Tarozzo Italy 21 507 0.8× 265 0.5× 61 0.3× 188 0.9× 90 0.5× 30 1.5k

Countries citing papers authored by J. Mark Treherne

Since Specialization
Citations

This map shows the geographic impact of J. Mark Treherne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mark Treherne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mark Treherne more than expected).

Fields of papers citing papers by J. Mark Treherne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mark Treherne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mark Treherne. The network helps show where J. Mark Treherne may publish in the future.

Co-authorship network of co-authors of J. Mark Treherne

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mark Treherne. A scholar is included among the top collaborators of J. Mark Treherne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mark Treherne. J. Mark Treherne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Treherne, J. Mark & Aline F. Miller. (2023). Novel hydrogels: are they poised to transform 3D cell-based assay systems in early drug discovery?. Expert Opinion on Drug Discovery. 18(3). 335–346.
2.
Scannell, Jack W., Jim Bosley, John A. Hickman, et al.. (2022). Predictive validity in drug discovery: what it is, why it matters and how to improve it. Nature Reviews Drug Discovery. 21(12). 915–931. 47 indexed citations
3.
Treherne, J. Mark, et al.. (2021). Converging global crises are forcing the rapid adoption of disruptive changes in drug discovery. Drug Discovery Today. 26(11). 2489–2495.
4.
Brunner, Daniela, Stefanie Flunkert, Joerg Neddens, et al.. (2017). SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer’s disease. Neuroscience Letters. 660. 96–102. 3 indexed citations
5.
Lo, Adrian C., Ina Tesseur, D. I. C. SCOPES, et al.. (2013). Dose-dependent improvements in learning and memory deficits in APPPS1-21 transgenic mice treated with the orally active Aβ toxicity inhibitor SEN1500. Neuropharmacology. 75. 458–466. 11 indexed citations
6.
O‘Hare, Eugene, D. I. C. SCOPES, Eun‐Mee Kim, et al.. (2013). Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's disease. The International Journal of Neuropsychopharmacology. 17(1). 117–126. 10 indexed citations
7.
O‘Hare, Eugene, Ross Jeggo, David Spanswick, et al.. (2012). Aβ oligomer toxicity inhibitor protects memory in models of synaptic toxicity. British Journal of Pharmacology. 167(2). 383–392. 15 indexed citations
8.
O‘Hare, Eugene, D. I. C. SCOPES, Eun‐Mee Kim, et al.. (2012). Orally bioavailable small molecule drug protects memory in Alzheimer's disease models. Neurobiology of Aging. 34(4). 1116–1125. 14 indexed citations
9.
O‘Hare, Eugene, et al.. (2010). RS-0406 Arrests Amyloid-β Oligomer-Induced Behavioural Deterioration In Vivo. Behavioural Brain Research. 210(1). 32–37. 16 indexed citations
10.
Treherne, J. Mark. (2006). Exploiting High-Throughput Ion Channel Screening Technologies in Integrated Drug Discovery. Current Pharmaceutical Design. 12(4). 397–406. 13 indexed citations
11.
Doig, Andrew J., Kelvin Stott, & J. Mark Treherne. (2004). Inhibitors of Amyloid Aggregation: Technologies for the Discovery of Novel Lead Compounds. Biotechnology and Genetic Engineering Reviews. 21(1). 197–214. 3 indexed citations
12.
Poyner, David R., Helen M. Cox, Mark Bushfield, J. Mark Treherne, & Melissa K. Demetrikopoulos. (2000). Neuropeptides in drug research. Birkhäuser Basel eBooks. 54. 121–149. 4 indexed citations
13.
Kenny, Barry, et al.. (1998). The application of high-throughput screening to novel lead discovery. Birkhäuser Basel eBooks. 51. 245–269. 46 indexed citations
14.
Treherne, J. Mark, et al.. (1997). The role of apoptosis in neurodegenerative diseases. Birkhäuser Basel eBooks. 48. 55–98. 16 indexed citations
15.
Newcombe, Jia, et al.. (1994). BINDING OF I-125 LABELED DENDROTOXIN TO DEMYELINATED HUMAN MULTIPLE-SCLEROSIS LESIONS. UCL Discovery (University College London). 1 indexed citations
16.
Treherne, J. Mark & Michael L.J. Ashford. (1992). Extracellular cations modulate the ATP sensitivity of ATP-K + channels in rat ventromedial hypothalamic neurons. Proceedings of the Royal Society B Biological Sciences. 247(1319). 121–124. 11 indexed citations
17.
Treherne, J. Mark & Michael L.J. Ashford. (1991). The regional distribution of sulphonylurea binding sites in rat brain. Neuroscience. 40(2). 523–531. 63 indexed citations
18.
Zou, Dong‐Jing, J. Mark Treherne, Randall R. Stewart, Norman R. Saunders, & J. G. Nicholls. (1991). Regulation of GABA B receptors by histamine and neuronal activity in the isolated spinal cord of neonatal opossum in culture. Proceedings of the Royal Society B Biological Sciences. 246(1315). 77–82. 12 indexed citations
19.
Ashford, Michael L.J., et al.. (1990). Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K+ channels. Pflügers Archiv - European Journal of Physiology. 415(4). 479–483. 287 indexed citations
20.
Treherne, J. Mark & J.M. Young. (1988). [3H]‐(+)‐N‐methyl‐4‐methyldiphenhydramine, a quaternary radioligand for the histamine H1‐receptor. British Journal of Pharmacology. 94(3). 797–810. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atsuko Kimura Breakdown of academic impact, for papers by Juan José Garrido Breakdown of academic impact, for papers by Donna Bozyczko‐Coyne Breakdown of academic impact, for papers by Carsten Strübing Breakdown of academic impact, for papers by Ludmila Mackerlova Breakdown of academic impact, for papers by Ross D. O’Shea Breakdown of academic impact, for papers by E. Barry Smalstig Breakdown of academic impact, for papers by Hiroko Sugiura Breakdown of academic impact, for papers by Sigismund Huck Breakdown of academic impact, for papers by Glauco Tarozzo
Rankless by CCL
2026